1. Home
  2. PMCB vs SQFT Comparison

PMCB vs SQFT Comparison

Compare PMCB & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • SQFT
  • Stock Information
  • Founded
  • PMCB 1996
  • SQFT 1999
  • Country
  • PMCB United States
  • SQFT United States
  • Employees
  • PMCB N/A
  • SQFT N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • SQFT Real Estate Investment Trusts
  • Sector
  • PMCB Health Care
  • SQFT Real Estate
  • Exchange
  • PMCB Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • PMCB 6.6M
  • SQFT 7.7M
  • IPO Year
  • PMCB N/A
  • SQFT 2020
  • Fundamental
  • Price
  • PMCB $0.80
  • SQFT $4.61
  • Analyst Decision
  • PMCB
  • SQFT
  • Analyst Count
  • PMCB 0
  • SQFT 0
  • Target Price
  • PMCB N/A
  • SQFT N/A
  • AVG Volume (30 Days)
  • PMCB 42.7K
  • SQFT 26.7K
  • Earning Date
  • PMCB 12-12-2025
  • SQFT 11-12-2025
  • Dividend Yield
  • PMCB N/A
  • SQFT N/A
  • EPS Growth
  • PMCB N/A
  • SQFT N/A
  • EPS
  • PMCB 0.01
  • SQFT N/A
  • Revenue
  • PMCB N/A
  • SQFT $17,525,364.00
  • Revenue This Year
  • PMCB N/A
  • SQFT $23.63
  • Revenue Next Year
  • PMCB N/A
  • SQFT N/A
  • P/E Ratio
  • PMCB $125.04
  • SQFT N/A
  • Revenue Growth
  • PMCB N/A
  • SQFT N/A
  • 52 Week Low
  • PMCB $0.75
  • SQFT $4.19
  • 52 Week High
  • PMCB $1.93
  • SQFT $23.00
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 29.41
  • SQFT 35.20
  • Support Level
  • PMCB $0.79
  • SQFT $4.70
  • Resistance Level
  • PMCB $0.93
  • SQFT $5.44
  • Average True Range (ATR)
  • PMCB 0.06
  • SQFT 0.43
  • MACD
  • PMCB -0.01
  • SQFT -0.14
  • Stochastic Oscillator
  • PMCB 16.01
  • SQFT 15.58

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: